Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

•Double umbilical cord blood transplantation and haploidentical post-transplantation cyclophosphamide with peripheral blood stem cell transplantation are useful strategies for treating adults with acute myelogenous leukemia in complete remission.•The conditioning regimen and graft-versus-host disease prophylaxis should be tailored to provide an antileukemia effect and prevent disease recurrence.